Metraipolis › archive › dc_eb72f4b43812
AOZORA study: 3-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis — Europe PMC PMID:41362697
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41362697
- DOI
- 10.1016/j.rpth.2025.103228
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:33:18.984Z
- SHA-256 of the archived text
f58a56736d5a0e6d4c95633e8dd6d6fd15e8b4792049c1a1041f6990e1160af8- Stable URL of this page
https://metraipolis.com/documento/dc_eb72f4b43812
How to cite
AOZORA study: 3-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis — Europe PMC PMID:41362697 — Europe PMC (en), https://europepmc.org/article/MED/41362697 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb72f4b43812 (Metraipolis archive dc_eb72f4b43812, sha256 f58a56736d5a0e6d4c95633e8dd6d6fd15e8b4792049c1a1041f6990e1160af8)
BibTeX
@misc{dceb72f4b43812,
title = {AOZORA study: 3-year interim analysis of safety and joint health in pediatric people with hemophilia A receiving emicizumab prophylaxis — Europe PMC PMID:41362697},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41362697},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb72f4b43812; sha256 f58a56736d5a0e6d4c95633e8dd6d6fd15e8b4792049c1a1041f6990e1160af8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41362697. Agents can read the archived copy with the MCP tool read_document.